Ms Colleran previously served as senior vice president of commercial operations for LifeCell with responsibility for sales and marketing, surgeon education, new product launches, business development, as well
The company has also appointed two new board members. The new members include Taras Silecky of Ascension Health Ventures and Ajit Singh, CEO of the image and knowledge
The CE marked Elucigene FH20 kit, validated for in vitro diagnostic use, can rapidly determine the 20 genetic mutations most commonly found in a UK-based population, that are
Mr Morgon joins from Schering-Plough France, where he managed the primary care operations in France for two years and the partnership with MSD. From 2004 to 2006, he
Assurance is a multi-center, open-label follow-up study of patients with relapsing multiple sclerosis (MS) treated with Avonex or placebo for at least two years in the Phase III
Belimumab is being developed by Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) under a co-development and commercialization agreement entered into in August 2006. The belimumab Phase III development
ViziLite Plus with TBlue is now available to 55% of the people in the western and eastern EU-member countries, said Zila. Zila has previously announced that it had
Based on the Safety Review Committee’s review of safety data from the first cohort of patients, the committee has recommended that the company open the second cohort of
The company has ended the trial as recommended by its independent data monitoring committee (IDMC) which observed an imbalance in deaths between the two treatment arms of the
In addition, the board of directors appointed Dr Spigelman as chairman of the company’s clinical oversight committee as well as a member of the compensation committee. Dr Spigelman
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.